Olema Pharmaceuticals, Inc. — Director's Dealing 2020

Nov 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Olema Pharmaceuticals, Inc. (OLMA)
CIK: 0001750284
Period of Report: 2020-09-18

Reporting Person: MCCORMICK FRANK (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-18	Stock Option (Right to Buy)	$4.824	A	56964	Acquired	2030-09-17	Common Stock (56964)	Direct
2020-11-18	Stock Option (Right to Buy)	$19.00	A	21520	Acquired	2030-11-17	Common Stock (21520)	Direct

Footnotes

F1: The shares subject to the option are fully vested.

F2: The shares subject to the option vest in a series of 12 successive equal monthy installments measured from June 1, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.